Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancerNoriko Hirai, Takaaki Sasaki|Translational Lung Cancer Research|2021Cited by 11